Bogni A - Search Results

1

The role of serum carcinoembryonic antigen (CEA) in the management of patients with colorectal carcinoma: the experience of the Istituto Tumori of Milan.

Seregni E, Bombardieri E, Bogni A, Crippa F, De Jager E, Buraggi GL. Seregni E, et al. Among authors: bogni a. Int J Biol Markers. 1992 Jul-Sep;7(3):167-70. doi: 10.1177/172460089200700308. Int J Biol Markers. 1992. PMID: 1431340

2

Evaluation of cytokeratin 19 serum fragments (CYFRA 21-1) in patients with lung cancer: results of a multicenter trial.

Bombardieri E, Seregni E, Bogni A, Ardit S, Belloli S, Busetto A, Caniello B, Castelli M, Cianetti A, Correale M, et al. Bombardieri E, et al. Among authors: bogni a. Int J Biol Markers. 1994 Apr-Jun;9(2):89-95. doi: 10.1177/172460089400900205. Int J Biol Markers. 1994. PMID: 7523547 Clinical Trial.

3

Mucin-like carcinoma-associated antigen (MCA) in breast cancer: clinical experience at the National Cancer Institute of Milan.

Seregni E, Crippa F, Botti C, Bellotti MG, Bogni A, Pizzichetta M, Bombardieri E. Seregni E, et al. Among authors: bogni a. Int J Biol Markers. 1993 Apr-Jun;8(2):124-9. doi: 10.1177/172460089300800209. Int J Biol Markers. 1993. PMID: 8366295

4

CA 15.3 determination in patients with breast cancer: clinical utility for the detection of distant metastases.

Bombardieri E, Pizzichetta M, Veronesi P, Seregni E, Bogni A, Maffioli L, Jotti GS, Bassetto MA, Zurrida S, Costa A. Bombardieri E, et al. Among authors: bogni a. Eur J Cancer. 1992;29A(1):144-6. doi: 10.1016/0959-8049(93)90595-7. Eur J Cancer. 1992. PMID: 1445733

5

CA 15.3 as a signal of undetectable breast cancer metastases in a follow-up period of 4 years.

Pizzichetta M, Bogni A, Seregni E, Maffioli L, de Jager E, Costa A, Bombardieri E. Pizzichetta M, et al. Among authors: bogni a. Int J Biol Markers. 1992 Jan-Mar;7(1):59-60. doi: 10.1177/172460089200700109. Int J Biol Markers. 1992. PMID: 1583349 No abstract available.

6

EIA/IRMA test for cytokeratin 19 determination.

Bogni A, Seregni E, Botti C, Foa P, Cataldo I, Crippa F, Bombardieri E. Bogni A, et al. Int J Biol Markers. 1993 Jul-Sep;8(3):200-1. doi: 10.1177/172460089300800312. Int J Biol Markers. 1993. PMID: 7506285 No abstract available.

7

Thymidine kinase (TK) activity as a prognostic parameter of survival in lymphoma patients.

Bogni A, Cortinois A, Grasselli G, Seregni E, Crippa F, Castellani MR, Bombardieri E. Bogni A, et al. J Biol Regul Homeost Agents. 1994 Oct-Dec;8(4):121-5. J Biol Regul Homeost Agents. 1994. PMID: 7660854

8

PSA-alpha 1-antichymotrypsin determination in patients with benign prostatic hyperplasia and prostatic cancer.

Bogni A, Seregni ET, Abregú AV, Boni R, Bombardieri E. Bogni A, et al. Int J Biol Markers. 1993 Apr-Jun;8(2):138-9. doi: 10.1177/172460089300800212. Int J Biol Markers. 1993. PMID: 7690059 No abstract available.

9

Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.

Crippa F, Agresti R, Seregni E, Greco M, Pascali C, Bogni A, Chiesa C, De Sanctis V, Delledonne V, Salvadori B, Leutner M, Bombardieri E. Crippa F, et al. Among authors: bogni a. J Nucl Med. 1998 Jan;39(1):4-8. J Nucl Med. 1998. PMID: 9443729 Free article.

10

Preliminary study on oncogene product immunohistochemistry (c-erbB-2, c-myc, ras p21, EGFR) in breast pathology.

Saccani Jotti G, Fontanesi M, Bombardieri E, Gabrielli M, Veronesi P, Bianchi M, Becchi G, Bogni A, Tardini A. Saccani Jotti G, et al. Among authors: bogni a. Int J Biol Markers. 1992 Jan-Mar;7(1):35-42. Int J Biol Markers. 1992. PMID: 1349907

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters